A detailed history of Rhumbline Advisers transactions in Danaher Corp stock. As of the latest transaction made, Rhumbline Advisers holds 1,179,512 shares of DHR stock, worth $285 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
1,179,512
Previous 1,233,726 4.39%
Holding current value
$285 Million
Previous $308 Million 6.37%
% of portfolio
0.3%
Previous 0.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$239.25 - $280.76 $13 Million - $15.2 Million
-54,214 Reduced 4.39%
1,179,512 $328 Million
Q2 2024

Aug 01, 2024

BUY
$235.51 - $267.98 $2.69 Million - $3.07 Million
11,438 Added 0.94%
1,233,726 $308 Million
Q1 2024

May 09, 2024

BUY
$224.58 - $256.19 $1.44 Million - $1.64 Million
6,421 Added 0.53%
1,222,288 $305 Million
Q4 2023

Feb 08, 2024

BUY
$185.1 - $233.13 $738,363 - $929,955
3,989 Added 0.33%
1,215,867 $281 Million
Q3 2023

Nov 09, 2023

BUY
$233.08 - $265.59 $168,283 - $191,755
722 Added 0.06%
1,211,878 $301 Million
Q2 2023

Aug 08, 2023

BUY
$224.99 - $256.14 $5.46 Million - $6.21 Million
24,260 Added 2.04%
1,211,156 $291 Million
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $3.81 Million - $4.41 Million
15,909 Added 1.36%
1,186,896 $299 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $10.4 Million - $12.2 Million
43,256 Added 3.84%
1,170,987 $311 Million
Q3 2022

Nov 10, 2022

BUY
$247.06 - $1507.4 $5.16 Million - $31.5 Million
20,899 Added 1.89%
1,127,731 $291 Million
Q2 2022

Aug 11, 2022

BUY
$237.11 - $299.66 $17.3 Million - $21.8 Million
72,851 Added 7.05%
1,106,832 $281 Million
Q1 2022

May 12, 2022

BUY
$257.27 - $315.76 $7.54 Million - $9.25 Million
29,292 Added 2.92%
1,033,981 $303 Million
Q4 2021

Feb 10, 2022

BUY
$292.08 - $329.01 $5.39 Million - $6.08 Million
18,470 Added 1.87%
1,004,689 $331 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $7.85 Million - $9.59 Million
-28,836 Reduced 2.84%
986,219 $300 Million
Q2 2021

Aug 05, 2021

SELL
$225.08 - $271.69 $10.1 Million - $12.1 Million
-44,670 Reduced 4.22%
1,015,055 $272 Million
Q1 2021

May 06, 2021

SELL
$212.38 - $245.9 $13.1 Million - $15.2 Million
-61,688 Reduced 5.5%
1,059,725 $239 Million
Q4 2020

Feb 10, 2021

BUY
$212.5 - $245.46 $1.85 Million - $2.13 Million
8,687 Added 0.78%
1,121,413 $249 Million
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $2.19 Million - $2.66 Million
-12,367 Reduced 1.1%
1,112,726 $240 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $4.66 Million - $6.4 Million
36,216 Added 3.33%
1,125,093 $199 Million
Q1 2020

May 06, 2020

SELL
$121.39 - $169.05 $2.88 Million - $4.01 Million
-23,724 Reduced 2.13%
1,088,877 $151 Million
Q4 2019

Feb 05, 2020

SELL
$133.47 - $153.48 $820,173 - $943,134
-6,145 Reduced 0.55%
1,112,601 $171 Million
Q3 2019

Oct 23, 2019

BUY
$135.4 - $146.47 $2.56 Million - $2.77 Million
18,911 Added 1.72%
1,118,746 $162 Million
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $650,999 - $749,264
-5,213 Reduced 0.47%
1,099,835 $157 Million
Q1 2019

May 01, 2019

SELL
$97.62 - $132.29 $1.3 Million - $1.76 Million
-13,317 Reduced 1.19%
1,105,048 $146 Million
Q4 2018

Jan 31, 2019

BUY
$94.85 - $109.54 $1.33 Million - $1.54 Million
14,074 Added 1.27%
1,118,365 $115 Million
Q3 2018

Nov 07, 2018

SELL
$98.13 - $108.9 $1.07 Million - $1.18 Million
-10,879 Reduced 0.98%
1,104,291 $120 Million
Q2 2018

Aug 06, 2018

BUY
$96.1 - $103.24 $288,300 - $309,720
3,000 Added 0.27%
1,115,170 $110 Million
Q1 2018

May 02, 2018

SELL
$92.16 - $103.8 $1.71 Million - $1.93 Million
-18,565 Reduced 1.64%
1,112,170 $109 Million
Q4 2017

Feb 09, 2018

BUY
$85.26 - $94.62 $1.33 Million - $1.47 Million
15,542 Added 1.39%
1,130,735 $105 Million
Q3 2017

Nov 06, 2017

BUY
$79.29 - $88.45 $88.4 Million - $98.6 Million
1,115,193
1,115,193 $95.7 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $176B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.